Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc > Overall

<< Previous

Bullboard Posts

Next >>

Post by Costanoon Aug 10, 2018 11:59am

89 Views

Post# 28441046

Overall

Was a great week for the stock. Volume was huge. Price surged. It pulled back which is good but didn’t give back all the gains. 3 cent climb a week is great. Plus the attention and anticipation is back. This ran to 28 cents from 5 cents in a few days a month ago. Next week might be handsome!!

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide